Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

dialnet-ar-18-ART0001511541

dialnet

Dialnet

Dialnet AR

RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 1, 2022, pags. 202-209

Spanish

Neumonía
Distrés respiratorio
enfermedad pulmonar aguda
SARS-CoV-2
COVID-19
Pneumonia
respiratory distress
acute lung disease
SARS-CoV-2
COVID-19

Neumonía
Distrés respiratorio
enfermedad pulmonar aguda
SARS-CoV-2
COVID-19
Pneumonia
respiratory distress
acute lung disease
SARS-CoV-2
COVID-19
Aguilar Luzuriaga, Carolina Estefanía
Sanchez Riera, Evelyn Esthela
Delgado Lazo, Kristel
Bohórquez Garcés, June Dennisse
Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

COVID-19 disease, or novel coronavirus, is a global pandemic of acute respiratory illness caused by the virus known as SARS-CoV-2. Most cases of COVID-19 occur in adults. Respiratory distress syndrome is an acute and diffuse lung disease that produces hypoxemia, de-creased lung compliance and increased dead space. The care of critically ill patients with COVID-19 pneumonia during the pandemic has been the most important challenge faced by the Intensive Medicine throughout its history. The treatment of pneumonia by COVID-19 has very limited evidence as it is a new disease, which has forced a permanent updating of care protocols A clinical case of a 73-year-old male patient, married, born in Quito and resident in Guayaquil, higher education, retired, religion: Catholic, laterality: right-handed. Diagnosed with Type 2 Diabetes Mellitus treated with Metformin, Empaglifozin, does not report allergies, surgical cleaning intervention for left diabetic foot. He states that he is a former smoker and social drinker, immunized against Covid-19: Astrazeneca x1 whose reason for consultation is Dyspnea, Tachypnea. Even when the relevant protocols for the clinical picture developed have been followed, the treated AKI cannot be overcome by the patient, which confirms the studies of being a picture of difficult prognosis. The effects of the new coronavirus have been exposed, but as a medical community we are still far from imposing a single guide for the management of the disease, even more so when the long-term effects of SARS-COv-2 in recovered patients are being known. As of the date of this investigation, certain elements are taken into account that can already be considered important to avoid greater severity than we have survived and lies in maintaining social distancing, complying with vaccination schedules and using face masks

Article

Aguilar Luzuriaga, Carolina Estefanía
Sanchez Riera, Evelyn Esthela
Delgado Lazo, Kristel
Bohórquez Garcés, June Dennisse

Aguilar Luzuriaga, Carolina Estefanía
Sanchez Riera, Evelyn Esthela
Delgado Lazo, Kristel
Bohórquez Garcés, June Dennisse

Aguilar Luzuriaga, Carolina Estefanía

Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San Francisco

distrés respiratorio agudo grave. neumonía por infección sars-cov-2: caso clínico en el hospital clínica san francisco

2022

https://dialnet.unirioja.es/servlet/oaiart?codigo=8294243

1767464012790890496

dialnet-ar-18-ART00015115412023-05-30Distrés respiratorio agudo grave. Neumonía por infección SARS-Cov-2: caso clínico en el hospital clínica San FranciscoAguilar Luzuriaga, Carolina EstefaníaSanchez Riera, Evelyn EsthelaDelgado Lazo, KristelBohórquez Garcés, June DennisseNeumoníaDistrés respiratorioenfermedad pulmonar agudaSARS-CoV-2COVID-19Pneumoniarespiratory distressacute lung diseaseSARS-CoV-2COVID-19COVID-19 disease, or novel coronavirus, is a global pandemic of acute respiratory illness caused by the virus known as SARS-CoV-2. Most cases of COVID-19 occur in adults. Respiratory distress syndrome is an acute and diffuse lung disease that produces hypoxemia, de-creased lung compliance and increased dead space. The care of critically ill patients with COVID-19 pneumonia during the pandemic has been the most important challenge faced by the Intensive Medicine throughout its history. The treatment of pneumonia by COVID-19 has very limited evidence as it is a new disease, which has forced a permanent updating of care protocols A clinical case of a 73-year-old male patient, married, born in Quito and resident in Guayaquil, higher education, retired, religion: Catholic, laterality: right-handed. Diagnosed with Type 2 Diabetes Mellitus treated with Metformin, Empaglifozin, does not report allergies, surgical cleaning intervention for left diabetic foot. He states that he is a former smoker and social drinker, immunized against Covid-19: Astrazeneca x1 whose reason for consultation is Dyspnea, Tachypnea. Even when the relevant protocols for the clinical picture developed have been followed, the treated AKI cannot be overcome by the patient, which confirms the studies of being a picture of difficult prognosis. The effects of the new coronavirus have been exposed, but as a medical community we are still far from imposing a single guide for the management of the disease, even more so when the long-term effects of SARS-COv-2 in recovered patients are being known. As of the date of this investigation, certain elements are taken into account that can already be considered important to avoid greater severity than we have survived and lies in maintaining social distancing, complying with vaccination schedules and using face masksLa enfermedad por COVID-19 o novel coronavirus, es una pandemia global de enfermedad respiratoria aguda causada por el virus conocido como SARS-CoV-2. La mayoría de los casos de COVID-19 ocurren en adultos. El síndrome de Distrés respiratorio es una enfermedad pulmonar aguda y difusa que produce hipoxemia, disminución de la compliance pulmonar y aumento del espacio muerto La atención a los pacientes críticos con neumonía por COVID-19 durante la pandemia ha sido el reto más importante afrontado por la Medicina Intensiva en toda su historia. El tratamiento de la neumonía por COVID-19 tiene una evidencia muy limitada al tratarse de una enfermedad nueva, lo que ha obligado a una permanente actualización de los protocolos asistenciales Se presenta un caso clínico de paciente masculino 73 años de edad, casado, nacido en Quito y residente en guayaquil, instrucción superior, jubilado, religión: católica, lateralidad: diestra. Diagnosticado con Diabetes mellitus tipo 2 con tratamiento de Metformina, Empaglifozina, no refiere alergias, intervención de limpieza quirúrgica por pie diabético izquierdo. Manifiesta ser ex fumador y bebedor social, Inmunizado para la Covid-19: Astrazeneca x1 cuyo motivo de consulta es Disnea, Taquipnea. Aun cuando se han seguido los protocolos pertinentes para el cuadro clínico desarrollado, el DRA abordado no puede ser superado por el paciente lo que confirma los estudios de ser un cuadro de difícil pronostico. Los efectos del nuevo coronavirus se han expuesto, pero estamos aún lejos, como comunidad médica imponer una guía única para el manejo de la enfermedad pues, más aún cuando se están conociendo los efectos a largo plazo de SARS-COv-2 en pacientes recuperados. A la fecha de esta investigación se tiene presente ciertos elementos que ya pueden ser considerados como importantes para evitar mayor gravedad de la que hemos sobrevivido y radica en mantener el distanciamiento social, cumplir con los esquemas de vacunación y utilizar tapabocas.2022text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8294243(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 1, 2022, pags. 202-209spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI